Submitted by Anonymous (not verified) on 27 February 2026 - 14:40
Human medicines European public assessment report (EPAR): Jeraygo, aprocitentan, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jeraygo, aprocitentan, Revision: 3, Status: Authorised